<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Purinergic Signal</journal-id>
      <journal-title>Purinergic Signalling</journal-title>
      <issn pub-type="ppub">1573-9538</issn>
      <issn pub-type="epub">1573-9546</issn>
      <publisher>
        <publisher-name>Springer Netherlands</publisher-name>
        <publisher-loc>Dordrecht</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18404440</article-id>
      <article-id pub-id-type="pmc">2072910</article-id>
      <article-id pub-id-type="publisher-id">9064</article-id>
      <article-id pub-id-type="doi">10.1007/s11302-007-9064-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Structural and functional evolution of the P2Y<sub>12</sub>-like receptor group</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Sch&#xF6;neberg</surname>
            <given-names>Torsten</given-names>
          </name>
          <address>
            <phone>+49-341-9722150</phone>
            <fax>+49-341-9722159</fax>
            <email>schoberg@medizin.uni-leipzig.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hermsdorf</surname>
            <given-names>Thomas</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Engemaier</surname>
            <given-names>Eva</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Engel</surname>
            <given-names>Kathrin</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Liebscher</surname>
            <given-names>Ines</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Thor</surname>
            <given-names>Doreen</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zierau</surname>
            <given-names>Klaas</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>R&#xF6;mpler</surname>
            <given-names>Holger</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Schulz</surname>
            <given-names>Angela</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Institute of Biochemistry, Molecular Biochemistry, Medical Faculty, University of Leipzig, Johannisallee 30, 04103 Leipzig, Germany </aff>
        <aff id="Aff2"><label>2</label>Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>6</day>
        <month>9</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2007</year>
      </pub-date>
      <volume>3</volume>
      <issue>4</issue>
      <fpage>255</fpage>
      <lpage>268</lpage>
      <history>
        <date date-type="received">
          <day>6</day>
          <month>7</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>7</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Springer Science + Business Media B.V. 2007</copyright-statement>
      </permissions>
      <abstract>
        <p>Metabotropic pyrimidine and purine nucleotide receptors (P2Y receptors) belong to the superfamily of G protein-coupled receptors (GPCR). They are distinguishable from adenosine receptors (P1) as they bind adenine and/or uracil nucleotide triphosphates or diphosphates depending on the subtype. Over the past decade, P2Y receptors have been cloned from a variety of tissues and species, and as many as eight functional subtypes have been characterized. Most recently, several members of the P2Y<sub>12</sub>-like receptor group, which includes the clopidogrel-sensitive ADP receptor P2Y<sub>12</sub>, have been deorphanized. The P2Y<sub>12</sub>-like receptor group comprises several structurally related GPCR which, however, display heterogeneous agonist specificity including nucleotides, their derivatives, and lipids. Besides the established function of P2Y<sub>12</sub> in platelet activation, expression in macrophages, neuronal and glial cells as well as recent results from functional studies implicate that several members of this group may have specific functions in neurotransmission, inflammation, chemotaxis, and response to tissue injury. This review focuses specifically on the structure-function relation and shortly summarizes some aspects of the physiological relevance of P2Y<sub>12</sub>-like receptor members.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Evolution</kwd>
        <kwd>G protein-coupled receptor</kwd>
        <kwd>Nucleotide receptor</kwd>
        <kwd>Orphan GPCR</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media B.V. 2007</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>Most cellular effects of nucleotides are mediated through two main families of specific cell surface receptors, the ionotropic P2X and metabotropic P2Y nucleotide receptors. The metabotropic receptors belong to the superfamily of G protein-coupled receptors (GPCR). The GPCR superfamily comprises at least five structurally distinct families/subfamilies (GRAFS classification) which share little sequence homology among each other [<xref ref-type="bibr" rid="CR1">1</xref>]. The rhodopsin-like receptors (also called family A or 1) form the largest family in vertebrates. Eight different mammalian P2Y (P2Y<sub>1, 2, 4, 6, 11&#x2013;14</sub>) receptor subtypes, all belonging to the rhodopsin-like receptors (family A), have been identified and proven to function as receptors for extracellular nucleotides so far [<xref ref-type="bibr" rid="CR2">2</xref>]. Based on their preferential agonists, P2Y receptors have been subclassified into adenine nucleotide-activated (P2Y<sub>1</sub>, P2Y<sub>11</sub>, P2Y<sub>12</sub>, P2Y<sub>13</sub>), pyrimidine nucleotide-activated (P2Y<sub>4</sub>, P2Y<sub>6</sub>), ATP/UTP-activated (P2Y<sub>2</sub>), and UDP-sugar-activated (P2Y<sub>14</sub>) receptors. Most structural and functional studies were performed with the classic P2Y receptors P2Y<sub>1</sub> and P2Y<sub>2</sub> [<xref ref-type="bibr" rid="CR3">3</xref>]. However, in comparison to other GPCR, large-scale structure/function data are rare, mainly due to difficulties in finding suitable P2Y-free heterologous expression systems [<xref ref-type="bibr" rid="CR4">4</xref>]. Pharmacological characterization on both native and recombinant P2Y receptors is further hampered by the release of endogenous nucleotides and the hydrolysis or conversion of exogenous and endogenous nucleotides by ectoenzymes (for review see [<xref ref-type="bibr" rid="CR5">5</xref>]). ATP and AMP are metabolized by cell surface enzymes, the ecto-NTPDase 1 (nucleoside triphosphate diphosphohydrolase 1, ectoapyrase, CD39, metabolizes ATP to AMP) and the 5&#x2032;-ectonucleotidase (CD73, metabolizes AMP to adenosine). In addition, a nucleoside diphosphokinase catalyzes the transfer of the gamma phosphate of nucleoside triphosphates to nucleoside diphosphates. For example, in the presence of ATP, nucleoside diphosphokinase catalyzes the conversion of UDP to UTP. These specific problems may have contributed to many false and controversial declarations of P2Y receptors being activated by nucleotides [<xref ref-type="bibr" rid="CR6">6</xref>&#x2013;<xref ref-type="bibr" rid="CR9">9</xref>]. Recent success in expressing GPCR in yeast, which is discussed below, may circumvent these problems and may engage structure-function-relation studies.</p>
      <p>Although in-depth phylogenetic analysis of GPCR groups indicates clustering of P2Y receptors, when compared with other GPCR of family A [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR10">10</xref>], the adenine nucleotide-activated P2Y<sub>1</sub> and P2Y<sub>12</sub>, for example, display only minor structural relation at the protein level. Phylogenetic analysis even revealed that nucleotide specificity e.g. for ADP evolved independently in P2Y<sub>1</sub> and P2Y<sub>12</sub>. So we suggest that grouping of P2Y receptors should be performed on phylogenetic aspects rather than on ligand specificity.</p>
      <p>Based on their amino acid sequences P2Y receptors can be subdivided into at least two groups (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). One comprises P2Y<sub>1, 2, 4, 6, 11</sub>, and the second group contains P2Y<sub>12&#x2013;14</sub>. Additionally, several other structurally related GPCR, such as CysLT1R, GPR91, GPR99, and GPR34, cluster into both groups (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). These receptors are activated by structurally different ligands such as leukotrienes, organic acids, and phospholipids. Probably because of their structural relation several P2Y receptors display agonist promiscuity. It was shown that not only ADP but also leukotriene E4 (LTE<sub>4</sub>) activates P2Y<sub>12</sub> at nanomolar concentrations [<xref ref-type="bibr" rid="CR11">11</xref>]. Cysteinyl leukotriene receptors (CysLT1R and CysLT2R) have been described to be activated by UDP in addition to activation by cysteinyl leukotrienes [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Further, there is evidence that CysLT1R antagonists, such as pranlukast and montelukast, inhibit activation of P2Y<sub>1</sub> and P2Y<sub>6</sub> by 2MeS-ADP (2-methylthio-ADP) and UDP, respectively [<xref ref-type="bibr" rid="CR14">14</xref>]. Although P2Y<sub>12</sub> and cysteinyl leukotriene receptors are clinically used targets for prevention of thrombocyte aggregation (clopidogrel) and treatment of asthma (montelukast), respectively, the structural basis and (patho)physiological relevance of dual/multiple agonist specificity is obscure. Close structural relations between P2Y and other non-nucleotide receptors as well as the mentioned examples of ligand promiscuity indicate that nucleotides are probably only one of many natural agonists on the genuine P2Y receptors.
<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Phylogenetic relation of human P2Y receptors. To evaluate the structural relation of P2Y receptors and related GPCR, amino acid sequences of human orthologs were aligned and phylogenetic relations were estimated using CLUSTAL W. The derived tree was essentially identical to former analysis [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. The P2Y<sub>12</sub>-like receptors cluster into a group (<italic>framed</italic>) that is distinct from other nucleotide receptors such as P2Y<sub>1</sub> and P2Y<sub>2</sub></p></caption><graphic position="anchor" xlink:href="11302_2007_9064_Fig1_HTML" id="MO1"/></fig></p>
    </sec>
    <sec id="Sec2">
      <title>Structural evolution of P2Y<sub>12</sub>-like GPCR</title>
      <sec id="Sec3">
        <title>Discovery and deorphanization of group members</title>
        <p>The ADP-(P2Y<sub>12</sub>)-like receptor group is the most recently identified P2Y receptor group and includes P2Y<sub>12</sub>, P2Y<sub>13</sub>, and P2Y<sub>14</sub> (see Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>, Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). Based on high structural similarity, the <italic>lyso</italic>-phosphatidylserine receptor (GPR34) and several orphan GPCR (GPR34-like, GPR82, GPR87, GPR171) are considered members of the structural P2Y<sub>12</sub>-like receptor group (3,11). Most members of this group were deorphanized by the so-called reverse pharmacology approach. The orphan receptors predicted from sequence data are now often used to ascertain the ligands by testing them on tissue extracts and subsequent fractionation or on huge libraries of bioactive compounds, whereas, traditionally, the bioactive ligand was used to identify the receptor (classic approach).
<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Members of the P2Y<sub>12</sub>-like receptor family</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Receptor</th><th>G protein coupling</th><th>Natural agonist</th><th>Tissue expression</th></tr></thead><tbody><tr><td>P2Y<sub>12</sub></td><td>G<sub>i</sub></td><td>ADP, CysLT-E4, phosphoribosyl pyrophosphate</td><td>Platelets, brain (glia) [<xref ref-type="bibr" rid="CR19">19</xref>]</td></tr><tr><td>P2Y<sub>13</sub></td><td>G<sub>i</sub></td><td>ADP, diadenosine triphosphate</td><td>Spleen and adult brain, lower expression in placenta, lung, liver, spinal cord, thymus, spleen, small intestine, uterus, stomach, testis, fetal brain, adrenal gland, lymph node, bone marrow, peripheral blood mononuclear cells, leukocytes [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]</td></tr><tr><td>P2Y<sub>14</sub></td><td>G<sub>i</sub></td><td>UDP-glucose, UDP-galactose, UDP-glucuronic acid, UDP-<italic>N</italic>-acetylglucosamine</td><td>Brain (astrocytes, glia), placenta, adipose tissue, stomach, intestine, spleen, lung (epithelium), heart [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR71">71</xref>]</td></tr><tr><td>GPR87</td><td>G<sub>i</sub></td><td>n.k</td><td>Placenta, thymus, small intestine, colon, prostate, uterus, testis, peripheral blood leukocytes [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]</td></tr><tr><td>GPR171</td><td>n.k</td><td>n.k</td><td>n.k</td></tr><tr><td>GPR34</td><td>G<sub>i</sub></td><td><italic>lyso</italic>-phosphatidylserine</td><td>Brain, glia cells, mast cells, spleen, heart, kidney, liver [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]</td></tr><tr><td>GPR82</td><td>n.k</td><td>n.k</td><td>Testes, epididymis (unpublished own results)</td></tr></tbody></table><table-wrap-foot><p>Based on phylogenetic analyses and structural similarities the seven GPCR clusters in a group which is distinct from other P2Y receptors (see Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Although they share structural features it appears from current studies that not all members are receptors for nucleotides. The table lists the currently known receptor agonists, the receptor&#x2019;s G protein specificity and expression pattern</p><p><italic>n.k</italic> not known</p></table-wrap-foot></table-wrap></p>
        <p>As the first member of the P2Y<sub>12</sub>-like receptor group P2Y<sub>14</sub> (synonyms KIAA0001, GPR105, VTR 15&#x2013;20) was identified [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>] and then deorphanized in the year 2000 [<xref ref-type="bibr" rid="CR17">17</xref>]. UDP-glucose was found to activate P2Y<sub>14</sub> by screening multiple receptors, each expressed in individual yeast strains, against a large library of over 700 known and putative natural GPCR agonists.</p>
        <p>In 2001, P2Y<sub>12</sub> (initially named SP1999) was discovered and identified as the platelet clopidogrel-sensitive ADP receptor by a number of groups [<xref ref-type="bibr" rid="CR18">18</xref>&#x2013;<xref ref-type="bibr" rid="CR21">21</xref>]. The P2Y<sub>12</sub> was deorphanized with both the classic and the reverse pharmacology approaches. Hollopeter et al. used subfractionated transcripts from platelets and isolated the cRNA (complementary RNA, encoding e.g. the P2Y<sub>12</sub> receptor) which mediated ADP-induced increases in K<sup>+</sup> current after injection into <italic>Xenopus</italic> oocytes [<xref ref-type="bibr" rid="CR19">19</xref>]. In contrast, fractionated rat spinal cord extracts were assayed for Ca<sup>2+</sup> mobilization in cells transiently transfected with P2Y<sub>12</sub> and chimeric G&#x3B1; subunit [<xref ref-type="bibr" rid="CR21">21</xref>]. Almost in parallel, ADP was shown to be an agonist for P2Y<sub>13</sub> (former GPR86), a very close structural neighbor of P2Y<sub>12</sub> [<xref ref-type="bibr" rid="CR22">22</xref>&#x2013;<xref ref-type="bibr" rid="CR24">24</xref>]. 2MeS-ADP is the most potent agonist at P2Y<sub>12</sub> followed by ADP, adenosine 5&#x2032;-O-2-thiodiphosphate, and ATP. (<italic>N</italic>)-methanocarba-2-methylthio-ADP, a highly potent agonist at P2Y<sub>1</sub>, exhibited no and only minor agonist activity at P2Y<sub>12</sub> and P2Y<sub>13</sub>, respectively [<xref ref-type="bibr" rid="CR25">25</xref>].</p>
        <p>Based on structural relations GPR34 [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>], GPR82 [<xref ref-type="bibr" rid="CR28">28</xref>], GPR87 [<xref ref-type="bibr" rid="CR29">29</xref>], and GPR171 (synonym H963) [<xref ref-type="bibr" rid="CR30">30</xref>] also belong to the P2Y<sub>12</sub>-like group (see Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). Except for GPR34, which was recently identified as a receptor for <italic>lyso</italic>-phosphatidylserine [<xref ref-type="bibr" rid="CR31">31</xref>] by a reverse pharmacology approach, all the other P2Y<sub>12</sub>-like receptors are still orphan GPCR.</p>
      </sec>
      <sec id="Sec4">
        <title>The evolutionary origins</title>
        <p>Based on structural similarities P2Y<sub>12</sub>-like receptors cluster into a group distinct from other P2Y receptors (see Figs.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref> and <xref rid="Fig2" ref-type="fig">2</xref>). This P2Y<sub>12</sub>-like receptor group can be subdivided into two subgroups. One subgroup encompasses P2Y<sub>12</sub>, P2Y<sub>13</sub>, P2Y<sub>14</sub>, GPR87, and GPR171, the other subgroup GPR34, GPR34-like, and GPR82 (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). This may suggest that both subgroups evolved from gene duplications starting from two related members. The grouping is further supported by shared genomic localization. Chromosomal clustering in the human genome is found for P2Y<sub>12</sub>, P2Y<sub>13</sub>, P2Y<sub>14</sub>, GPR87, and GPR171 at 3q24-3q25 as well as for GPR34 and GPR82 at Xp11.4. This clustering is evolutionary well preserved. In the zebrafish genome P2Y<sub>12</sub>, P2Y<sub>14</sub>/GPR87, and GPR171 cluster at chromosome 15 and GPR34 type 2 and GPR82 are tandemly arranged at chromosome 9. Gene clustering is not only found for vertebrate P2Y<sub>12</sub>-like receptors but also for several other GPCR genes. Multiple copies of related GPCR genes, such as the human protease-activated receptors on 5q13, trace amine-associated receptors (TAAR, human 6q23.2), and CC-chemokine receptors (human 3p21.3), are the result of intrachromosomal gene duplications. The most impressive example is found in odorant receptors, where in humans, chromosome 11 contains nearly half of the odorant receptor repertoire, including a single cluster of more than 100 odorant receptors [<xref ref-type="bibr" rid="CR32">32</xref>]. Gene amplification can be viewed as a dynamic and reversible regulatory mechanism that facilitates adaptation to variable environments. Clustered genes may confer selective benefits via their ability to be co-regulated and co-amplified. Indeed, even transcripts encoding a fusion protein of GPR34 and GPR82 have been observed (own unpublished results). However, the biological relevance of P2Y<sub>12</sub>-like receptor clustering in respect to transcriptional activity at their respective genomic loci, co-regulation, and transcript diversity need to be determined in the future.
<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Evolutionary origin of P2Y<sub>12</sub>-like receptors. To subclassify and evaluate the phylogenetic relations between the P2Y<sub>12</sub>-like receptors, the amino acid sequences of orthologs from one species of each vertebrate class (if available) were aligned using CLUSTAL W (identity matrices) and a phylogenetic tree was constructed (1,000 iterations). Bootstrap values &gt;600 were considered as significant to support a new branch</p></caption><graphic position="anchor" xlink:href="11302_2007_9064_Fig2_HTML" id="MO2"/></fig></p>
        <p>Since P2Y<sub>12</sub>, P2Y<sub>14</sub>/GPR87, GPR34, and GPR34-like are all found in sharks (<italic>Mustelus manazo</italic>, <italic>Carcharodon carcharias</italic>) and chimeras (<italic>Callorhinchus milii</italic>) one can assume that P2Y<sub>12</sub>-like receptors arose more than 450 million years (Myr) ago, before cartilaginous and bony fish split. Our own polymerase chain reaction (PCR) amplification attempts as well as the ongoing lamprey (<italic>Petromyzon marina</italic>) and sea urchin (<italic>Strongylocentrotus purpuratus</italic>) genome projects revealed no P2Y<sub>12</sub>-like sequences yet, suggesting their origin in the very early <italic>Gnathostomata</italic> or, less likely, a loss in agnate and all non-vertebrates.</p>
        <p>Gene duplication can be a primary source of the genetic material from which genes with new functions evolve. One copy of a duplicated gene may become mutated and acquire unique functionality without risking the fitness of the organism ensured by the homolog. On the other hand, if not advantageous, continuous accumulation of mutations (neutral drift) will eliminate one of the genes, a process named pseudogenization. In fish genomes, there is only one respective ortholog with relation to P2Y<sub>12</sub>/P2Y<sub>13</sub> and to GPR87/P2Y<sub>14</sub>. In the case of P2Y<sub>12</sub>/P2Y<sub>13</sub> the fish ortholog is more closely related to P2Y<sub>12</sub> implicating that P2Y<sub>13</sub> evolved later in tetrapod evolution probably by P2Y<sub>12</sub> duplication. However, one cannot rule out that the gene was eliminated in the common ancestor of sharks and bony fishes. The evolutionary mechanism of P2Y<sub>14</sub> and GPR87 evolvement remains unsolved since their structural relation to the fish orthologs is similar. The absence of P2Y<sub>14</sub> in the African craw frog (<italic>Xenopus</italic>) genome but the presence of ortholog sequences in all other sequenced tetrapod genomes does not necessarily implicate that P2Y<sub>14</sub> derived from GPR87 in early tetrapod evolution. Again, P2Y<sub>14</sub> gene loss in amphibians must be considered.</p>
        <p>Orthologs of GPR34, GPR87/P2Y<sub>14</sub>, and P2Y<sub>12</sub> are found in all tetrapods and bony and cartilaginous fishes investigated so far. However, not all members of the P2Y<sub>12</sub>-like group appear to be present in all vertebrate classes. GPR82 has an ortholog in zebrafish but is not yet found in the genomes of pufferfishes and the lizard (<italic>Anolis carolinensis</italic>) genome. Although GPR171 is found in reptiles, birds, mammals, zebrafish, and chimera it appears to be absent in African craw frog, stickleback, and pufferfishes. This may implicate specific functions of some P2Y<sub>12</sub>-like receptors which are less important in some species or are compensated by other receptors and mechanisms.</p>
        <p>Signatures of gene inactivation (pseudogenization) are rarely found for members of the P2Y<sub>12</sub>-like group. Following gene duplication in the common ancestor of evolutionary basic fishes, like eels and carps [<xref ref-type="bibr" rid="CR33">33</xref>], pseudogenization of one GPR34 subtype was identified in a salmon species (Keta salmon) (own unpublished results). The GPR34-like receptor is an evolutionary old P2Y<sub>12</sub>-like receptor being present in cartilaginous and bony fishes, amphibians, and birds but not in mammals (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). Sequences with residual relation to the GPR34-like receptor are found in the platypus genome but it is most likely a pseudogene.</p>
      </sec>
      <sec id="Sec5">
        <title>Genomic organization of P2Y<sub>12</sub>-like receptors</title>
        <p>Comparison of transcript and genomic sequences provides information on intron/exon structure of a GPCR gene. Since the gain or loss of spliceosomal introns are unique events in evolution, they can serve as markers for phylogenetic analysis. Further, such analyses may reveal splice variants and may be informative about the promoter structure and gene regulation. Introns are the basis of alternative splicing, exon skipping, and RNA editing events and, therefore, can contribute to receptor diversity at a supragenomic level.</p>
        <p>Most coding regions of human P2Y<sub>12</sub>-like receptors do not contain introns (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>). One exception is GPR87 where the genomic sequence encoding the receptor&#x2019;s N terminus is interrupted by an intron in mammalian and avian orthologs. Another intron which is rarely removed (cryptic intron) has been identified in the N terminus-encoding sequence of GPR34 [<xref ref-type="bibr" rid="CR34">34</xref>].
<table-wrap id="Tab2"><label>Table&#xA0;2</label><caption><p>Genomic organization of P2Y<sub>12</sub>-like GPCR. <italic>n.a.</italic> not analyzed because of lack of mRNA information</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Member</th><th>Number of introns in the 5&#x2032; non-coding region</th><th>Number of introns in the coding region</th><th>Approx. size of genomic region<sup>a</sup></th></tr></thead><tbody><tr><td colspan="4">P2Y<sub>12</sub></td></tr><tr><td>&#xA0;Human</td><td>1&#x2013;2</td><td>&#x2212;</td><td>47&#xA0;kbp (2 different transcript starts)</td></tr><tr><td>&#xA0;Mouse</td><td>4</td><td>&#x2212;</td><td>46.5&#xA0;kbp</td></tr><tr><td>&#xA0;Chicken</td><td>n.a.</td><td>&#x2212;<sup>b</sup></td><td>n.a. (&gt;1&#xA0;kbp)</td></tr><tr><td>&#xA0;African clawed frog</td><td>&#x2212;</td><td>1 (N terminus)</td><td>4&#xA0;kbp</td></tr><tr><td>&#xA0;Zebrafish</td><td>n.a.</td><td>&#x2212;<sup>b</sup></td><td>n.a. (&gt;1&#xA0;kbp)</td></tr><tr><td>&#xA0;Stickleback</td><td>1</td><td>1 (TMD2)</td><td>2&#xA0;kbp</td></tr><tr><td>&#xA0;Pufferfish</td><td>n.a.</td><td>1 (TMD2)</td><td>&gt;2&#xA0;kbp</td></tr><tr><td colspan="4">P2Y<sub>13</sub></td></tr><tr><td>&#xA0;Human</td><td>&#x2212;</td><td>1 (rare transcript, N terminus, NM_176894) </td><td>3.2&#xA0;kp (2 different transcript starts)</td></tr><tr><td>&#xA0;Mouse</td><td>1</td><td>&#x2212;</td><td>3&#xA0;kbp</td></tr><tr><td>&#xA0;Chicken</td><td>n.a.</td><td>&#x2212;<sup>b</sup></td><td>n.a. (&gt;1&#xA0;kbp)</td></tr><tr><td>&#xA0;African clawed frog</td><td>&#x2212;</td><td>1 (N terminus)</td><td>14&#x2013;19&#xA0;kbp</td></tr><tr><td colspan="4">P2Y<sub>14</sub></td></tr><tr><td>&#xA0;Human</td><td>2</td><td>&#x2212;</td><td>66&#xA0;kbp (2 different transcript starts)</td></tr><tr><td>&#xA0;Mouse</td><td>1&#x2013;2</td><td>&#x2212;</td><td>16&#xA0;kbp</td></tr><tr><td>&#xA0;Chicken</td><td>n.a.</td><td>&#x2212;<sup>b</sup></td><td>n.a. (&gt;1&#xA0;kbp)</td></tr><tr><td colspan="4">GPR87</td></tr><tr><td>&#xA0;Human</td><td>1</td><td>1 (N terminus)</td><td>22.7&#xA0;kbp</td></tr><tr><td>&#xA0;Mouse</td><td>1</td><td>1 (N terminus)</td><td>16&#xA0;kbp</td></tr><tr><td>&#xA0;Chicken</td><td>2</td><td>1 (N terminus)</td><td>9.5&#xA0;kbp</td></tr><tr><td>&#xA0;African clawed frog</td><td>n.a.</td><td>&#x2212;<sup>b</sup></td><td>n.a. (&gt;1&#xA0;kbp)</td></tr><tr><td colspan="4">P2Y<sub>14</sub>/GPR87</td></tr><tr><td>&#xA0;Zebrafish</td><td>n.a.</td><td>&#x2212;<sup>b</sup></td><td>n.a. (&gt;1&#xA0;kbp)</td></tr><tr><td>&#xA0;Pufferfish</td><td>n.a.</td><td>&#x2212;<sup>b</sup></td><td>n.a. (&gt;1&#xA0;kbp)</td></tr><tr><td colspan="4">GPR171</td></tr><tr><td>&#xA0;Human</td><td>2</td><td>&#x2212;</td><td>5&#xA0;kbp</td></tr><tr><td>&#xA0;Mouse</td><td>1</td><td>&#x2212;</td><td>4.5&#xA0;kbp</td></tr><tr><td>&#xA0;Chicken</td><td>1</td><td>&#x2212;</td><td>2.3&#xA0;kbp</td></tr><tr><td>&#xA0;Zebrafish</td><td>n.a.</td><td>&#x2212;<sup>b</sup></td><td>n.a. (&gt;1&#xA0;kbp)</td></tr><tr><td colspan="4">GPR82</td></tr><tr><td>&#xA0;Human</td><td>2</td><td>&#x2212;</td><td>4&#xA0;kbp</td></tr><tr><td>&#xA0;Mouse</td><td>2&#x2013;3</td><td>&#x2212;</td><td>6&#xA0;kbp</td></tr><tr><td>&#xA0;Chicken</td><td>n.a.</td><td>&#x2212;<sup>b</sup></td><td>n.a. (&gt;1&#xA0;kbp)</td></tr><tr><td>&#xA0;African clawed frog</td><td>n.a.</td><td>&#x2212;<sup>b</sup></td><td>n.a. (&gt;1&#xA0;kbp)</td></tr><tr><td>&#xA0;Zebrafish</td><td>n.a.</td><td>&#x2212;<sup>b</sup></td><td>n.a. (&gt;1&#xA0;kbp)</td></tr><tr><td colspan="4">GPR34</td></tr><tr><td>&#xA0;Human</td><td>3&#x2013;4</td><td>1 cryptic (N terminus)</td><td>8.2&#xA0;kbp</td></tr><tr><td>&#xA0;Mouse</td><td>3&#x2013;4</td><td>&#x2212;</td><td>9.1&#xA0;kbp</td></tr><tr><td>&#xA0;Chicken</td><td>1</td><td>&#x2212;</td><td>2.5&#xA0;kbp</td></tr><tr><td>&#xA0;African clawed frog</td><td>2</td><td>&#x2212;</td><td>5.2&#xA0;kbp</td></tr><tr><td colspan="4">&#xA0;Zebrafish</td></tr><tr><td>&#xA0;&#xA0;Type 1</td><td>1</td><td>&#x2212;</td><td>7.3&#xA0;kbp</td></tr><tr><td>&#xA0;&#xA0;Type 2</td><td>&#x2212;</td><td>&#x2212;</td><td>1.2&#xA0;kbp</td></tr><tr><td>&#xA0;Pufferfish</td><td>n.a.</td><td>&#x2212;<sup>b</sup></td><td>n.a. (&gt;1&#xA0;kbp)</td></tr></tbody></table><table-wrap-foot><p>Except for GPR87, human P2Y<sub>12</sub>-like receptor members contain no intron in the coding region. However, this intronless gene structure is not well preserved in all vertebrates. The table summarizes the number of introns within the 5&#x2032; and coding region of selected vertebrate genes and estimates the size of the gene</p><p><sup>a</sup>Based on the 5&#x2032; longest transcript</p><p><sup>b</sup>Complete open reading frame within the genomic sequence but intron within the very N terminus cannot be ruled out because of lack of mRNA information</p></table-wrap-foot></table-wrap></p>
        <p>The genomic organization of the individual P2Y<sub>12</sub>-like receptor genes is not well conserved during vertebrate evolution (see Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>). For example, the P2Y<sub>12</sub> gene gained an intron in bony fish evolution disrupting the open reading frame of the transmembrane domain 2 (TMD2)-encoding part. Similarly, one of the two GPR34 paralog genes acquired an intron in the more recent bony fish evolution [<xref ref-type="bibr" rid="CR33">33</xref>]. The two long-standing alternative explanations for the origin of introns, the intron-early theory and intron-late theory, remain a matter of continuous debate not only for GPCR [<xref ref-type="bibr" rid="CR35">35</xref>]. The intron-early theory suggests that introns are extremely ancient characteristics of genes and that early genes were created through the intron-mediated shuffling of exons. However, numerous gene and genome comparison studies provided evidence that at least some introns are more recently acquired (intron-late theory). The P2Y<sub>12</sub>-like receptor group is, therefore, a nice example where introns were acquired in the coding region in some species during more recent evolution.</p>
        <p>In contrast to the coding region, the 5&#x2032; region of most members of the P2Y<sub>12</sub>-like receptor group displays a distinct intron/exon organization with sometimes multiple transcription starts. Also, the gene sizes strongly differ between the individual and even closely related receptors. Introns in the 3&#x2032;-untranslated region (UTR) of P2Y<sub>12</sub>-like receptors have not been found yet. Large and complex organized 5&#x2032; non-coding regions of a gene may provide the basis for multiple promoter regions, cis-acting elements, and a variable 5&#x2032; UTR of the mRNA. Alternative structures of the 5&#x2032; UTR can contribute to expression regulation and alternative translation start points. For example, 5&#x2032; UTRs often contain small open reading frames (ORF) which can be translated via leaky scanning at the ribosome. Such leaky scanning can reduce translation of the downstream main ORF as shown for several genes including GPCR [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>].</p>
        <p>It is of interest to note that both genes, GPR34 and GPR82, are located in antisense orientation within a large intron of the CASK gene. This position is conserved during vertebrate evolution. The CASK gene encodes a calcium/calmodulin-dependent serine protein kinase that is a member of the membrane-associated guanylate kinase (MAGUK) protein family. Since GPR34 and GPR82 transcripts are antisense orientated to CASK one can speculate that transcripts may regulate expression of CASK or vice versa. Such hypotheses will be addressed in receptor-deficient mouse models (see below) in the future.</p>
      </sec>
      <sec id="Sec6">
        <title>Key residues defining the individual member</title>
        <p>Many attempts have been made to identify structural signatures which are helpful in annotation and grouping of P2Y receptors. On the basis of available sequence data for validated P2Y receptors, key residues were extracted to define P2Y<sub>12</sub>-like and P2Y<sub>1</sub>-like receptor groups [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. In recent studies, we have shown for several GPCR that a significant number of orthologs is required for identification of functional motifs and key residues [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR40">40</xref>&#x2013;<xref ref-type="bibr" rid="CR42">42</xref>]. By mining public databases and by amplifying and sequencing P2Y<sub>12</sub>-like orthologs we have acquired large sets of sequences of P2Y<sub>12</sub> (74 orthologs), P2Y<sub>13</sub> (31 orthologs), P2Y<sub>14</sub> (38 orthologs), GPR87 (51 orthologs), GPR171 (41 orthologs), GPR82 (34 orthologs), and GPR34 (133 orthologs) to determine structural conservation of the members and to identify amino acid sequence motifs and key residues that are unique for the P2Y<sub>12</sub>-like receptor group and the individual members (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). These data sets were obtained from vertebrate species ranging from evolutionary old bony and cartilaginous fishes to the more modern mammals representing 450 Myr of evolution. The overall identity between P2Y<sub>12</sub>-like members is rather low ranging from 19% amino acid identity (human GPR82 vs human GPR87) to 47% (human P2Y<sub>12</sub> and human P2Y<sub>13</sub>). Between the respective fish and mammal receptor orthologs P2Y<sub>12</sub> (~49%) shows the highest identity followed by GPR171 (~48%), GPR34 (~40%), and GPR82 (~35%). Since not all P2Y<sub>12</sub>-like GPCR have orthologs in all vertebrate classes, we analyzed the structural conservation within this receptor group by comparing <italic>K</italic><sub>a</sub>/<italic>K</italic><sub>s</sub> values (ratio of the number of nonsynonymous substitutions per nonsynonymous site and the number of synonymous&#x2014;or silent&#x2014;substitutions per synonymous&#x2014;or silent&#x2014;site) of the P2Y<sub>12</sub>-like receptor ortholog set from species containing all group members (Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>). Although all P2Y<sub>12</sub>-like receptors display a purifying selection mode of evolution (<italic>K</italic><sub>a</sub>/<italic>K</italic><sub>s</sub> &lt;&lt;1 indicates high conservation and elimination of deleterious mutations), there are significant differences between the members of this receptor group. P2Y<sub>12</sub> and GPR87 were kept most conserved during evolution in birds and mammals. By contrast, GPR82 appears to be less constrained as already indicated by a relatively low conservation at the amino acid level (see above).
<fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Conserved residues in P2Y<sub>12</sub>-like receptors. To identify conserved group and member-specific positions the amino acid sequences of P2Y<sub>12</sub> (74 orthologs), P2Y<sub>13</sub> (31 orthologs), P2Y<sub>14</sub> (38 orthologs), GPR87 (51 orthologs), GPR171 (41 orthologs), GPR82 (34 orthologs), and GPR34 (133 orthologs) were aligned using CLUSTAL W. Residues that are 100% conserved among the respective orthologs were boxed. Only a few positions are almost fully conserved among all members of the P2Y<sub>12</sub>-like group (position number refers to the relative numbering system by Ballesteros and Weinstein [<xref ref-type="bibr" rid="CR73">73</xref>]): TMD1: Phe/Tyr<sup>1.39</sup>, Phe<sup>1.57</sup>; TMD2: Leu<sup>2.43</sup>, Asn/Asp<sup>2.50</sup>, Pro/Ala<sup>2.58</sup>; TMD3: Tyr/His<sup>3.33</sup>, Arg/Gln<sup>3.50</sup>; TMD4: Trp<sup>4.50</sup>; TMD6: Cys/Ser<sup>6.47</sup>; Pro<sup>6.50</sup>; TMD7: Asp<sup>7.49</sup>, Pro<sup>7.50</sup>, and the two Cys residues bridging extracellular loops 1 and 2. The approximate positions of the seven transmembrane domains (<italic>TMD</italic>) are given above the sequences</p></caption><graphic position="anchor" xlink:href="11302_2007_9064_Fig3_HTML" id="MO3"/></fig><table-wrap id="Tab3"><label>Table&#xA0;3</label><caption><p>Sequence conservation of P2Y<sub>12</sub>-like GPCR</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Receptor</th><th><italic>K</italic><sub>a</sub>/<italic>K</italic><sub>s</sub></th><th>Pi</th></tr><tr><th>(mean &#xB1; SD)</th><th>(mean &#xB1; SD)</th></tr></thead><tbody><tr><td>P2Y<sub>12</sub></td><td>0.049&#x2009;&#xB1;&#x2009;0.018</td><td>0.145&#x2009;&#xB1;&#x2009;0.022</td></tr><tr><td>P2Y<sub>13</sub></td><td>0.141&#x2009;&#xB1;&#x2009;0.070</td><td>0.187&#x2009;&#xB1;&#x2009;0.023</td></tr><tr><td>P2Y<sub>14</sub></td><td>0.103&#x2009;&#xB1;&#x2009;0.036</td><td>0.190&#x2009;&#xB1;&#x2009;0.024</td></tr><tr><td>GPR87</td><td>0.046&#x2009;&#xB1;&#x2009;0.027</td><td>0.134&#x2009;&#xB1;&#x2009;0.018</td></tr><tr><td>GPR171</td><td>0.078&#x2009;&#xB1;&#x2009;0.012</td><td>0.158&#x2009;&#xB1;&#x2009;0.021</td></tr><tr><td>GPR34</td><td>0.082&#x2009;&#xB1;&#x2009;0.037</td><td>0.137&#x2009;&#xB1;&#x2009;0.026</td></tr><tr><td>GPR82</td><td>0.202&#x2009;&#xB1;&#x2009;0.049</td><td>0.167&#x2009;&#xB1;&#x2009;0.034</td></tr></tbody></table><table-wrap-foot><p>To compare the sequence conservation of P2Y<sub>12</sub>-like receptors, ortholog sequences [relative positions 1.48 (in TMD1) to 7.68 (in C-term)] from 18 species were aligned and DNA polymorphism analyses were performed using DnaSP (version 4.1). The <italic>K</italic><sub>a</sub>/<italic>K</italic><sub>s</sub> ratio is calculated from the number of nonsynonymous substitutions per nonsynonymous site (<italic>K</italic><sub>a</sub>) and the number of synonymous substitutions per synonymous site (<italic>K</italic><sub>s</sub>) for any pair of sequences. The nucleotide diversity (Pi) is the average number of nucleotide differences per site between two sequences. The orthologs of the following species were analyzed because their genome contained all members of the P2Y<sub>12</sub>-like group: <italic>Bos taurus, Equus caballus, Canis familiaris, Pteropus vampyrus, Ornithorhynchus anatinus, Monodelphis domestica, Callithrix jacchus, Pan troglodytes, Homo sapiens, Macaca mulatta, Microcebus murinus, Pongo pygmaeus, Tarsius syrichta, Cavia porcellus, Mus musculus, Rattus norvegicus, Tursiops truncates, Gallus gallus</italic></p></table-wrap-foot></table-wrap></p>
        <p>As shown in Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>, members of the P2Y<sub>12</sub>-like group share only eight fully conserved residues (Phe<sup>1.57</sup>, Leu<sup>2.43</sup>, Trp<sup>4.50</sup>, Pro<sup>6.50</sup>, Asp<sup>7.49</sup>, Pro<sup>7.50</sup>, and both Cys residues bridging extracellular loops 1 and 2) when sequences of more than 400 receptors of this group are compared. Although the ADP receptors P2Y<sub>12</sub> and P2Y<sub>13</sub> share more than 50 fully conserved residues none of these conserved residues is exclusively found in P2Y<sub>12</sub> and P2Y<sub>13</sub> but rather present also in other P2Y<sub>12</sub>-like receptors (see Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). Further, only a few residues are member specifically conserved (GPR171: Gln<sup>3.53</sup> and Asn<sup>5.59</sup>; P2Y<sub>13</sub>: Met<sup>7.48</sup>; GPR82: Leu<sup>6.44</sup> and Asp<sup>7.57</sup>; GPR34: Met<sup>7.52</sup>) and have not been found in other P2Y<sub>12</sub>-like receptors so far. These facts suggest that ligand and signaling specificity is determined by a combination of many, more or less conserved determinants. It has been proposed that His<sup>6.52</sup>/Arg<sup>6.55</sup> and Lys<sup>7.35</sup>/Glu<sup>7.36</sup>/Leu<sup>7.39</sup> within TMD6 and the ECL3, respectively, may present such motifs required for nucleotide binding [<xref ref-type="bibr" rid="CR38">38</xref>]. However, such residue combination is also present in some GPR87, GPR171, and GPR34 orthologs which are not activated by ADP. This does not rule out that these residues are involved in nucleotide binding of e.g. P2Y<sub>12</sub> but it implicates additional positions which determine ligand specificity. In-depth structure-function analysis e.g. by mutagenesis studies are required to identify key positions and their structural properties.</p>
      </sec>
    </sec>
    <sec id="Sec7">
      <title>Physiological relevance of P2Y<sub>12</sub>-like receptors</title>
      <sec id="Sec8">
        <title>Functional characterization of P2Y<sub>12</sub>-like receptors in heterologous expression systems</title>
        <p>Signal transduction of the ADP receptor P2Y<sub>12</sub> via pertussis toxin-sensitive G<sub>i</sub> proteins and adenylyl cyclase inhibition is well established [<xref ref-type="bibr" rid="CR22">22</xref>]. Similar G<sub>i</sub> protein-coupling specificity was found for P2Y<sub>13</sub> [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR24">24</xref>], P2Y<sub>14</sub> [<xref ref-type="bibr" rid="CR43">43</xref>], and <italic>lyso</italic>-PS receptor GPR34 [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Because adenylyl cyclase inhibition assays are usually less sensitive and robust several other experimental setups were established to measure function of P2Y<sub>12</sub>-like GPCR. It has been shown that G&#x3B1;<sub>15</sub> and G&#x3B1;<sub>16</sub> can be activated by a wide variety of GPCR [<xref ref-type="bibr" rid="CR44">44</xref>]. The ability of G&#x3B1;<sub>16</sub> to bypass the selectivity of receptor/G protein interaction was also useful to measure activation of P2Y<sub>13</sub> [<xref ref-type="bibr" rid="CR45">45</xref>]. It has been demonstrated that replacement of the four or five C-terminal amino acids of G&#x3B1;<sub>q</sub> with the corresponding G&#x3B1;<sub>i</sub> residues (referred to as G<sub>&#x394;6qi4</sub> [<xref ref-type="bibr" rid="CR46">46</xref>]) confers the ability to stimulate the PLC-&#x3B2; pathway onto G<sub>i</sub>-coupled receptors [<xref ref-type="bibr" rid="CR47">47</xref>]. Successful heterologous expression and activation by applying chimeric G&#x3B1;<sub>qi4</sub> has been demonstrated for P2Y<sub>12&#x2013;14</sub> and <italic>lyso</italic>-PS receptor GPR34 [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR48">48</xref>].</p>
        <p>We have previously shown that P2Y<sub>12</sub> as well as the <italic>lyso</italic>-PS receptor GPR34 display increased basal activity in functional assays when compared with other GPCR [<xref ref-type="bibr" rid="CR33">33</xref>]. This high basal activity can be either discussed as the natural ground state of the receptor activity equilibrium or as the effect of receptor agonists that are present in the cell culture medium or that are released from cells. Analyzing mutations in the highly conserved DRY motif of P2Y<sub>12</sub> we recently showed that basal activity is abolished in the DHY mutant but agonist-induced activation remains intact (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>). We conclude that the basal activity of the ADP receptor is rather a genuine property of this receptor and not due to continuous stimulation by agonists. High basal activity appears to be a general feature of all members of the P2Y<sub>12</sub>-like receptor group. In our initial ortholog screen we identified two GPR87/P2Y<sub>14</sub> receptors, carp GPR87/P2Y<sub>14</sub> types 1a and 1b (AY241103, AY241102), which differ in only ten amino acid positions. Interestingly, carp GPR87/P2Y<sub>14</sub> type 1b displays higher basal activity and studies are ongoing to identify residues that promote constitutive activity.
<fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>High basal activity is a genuine property of P2Y<sub>12</sub>. Basal activity of the wild-type P2Y<sub>12</sub> (DRY motif) and a mutant P2Y<sub>12</sub> (DHR motif) was determined in transiently transfected COS-7 cells. G<sub>i</sub> coupling of P2Y<sub>12</sub> was rerouted to IP production by co-transfection of a chimeric G protein G<sub>&#x394;6qi4</sub> [<xref ref-type="bibr" rid="CR46">46</xref>]</p></caption><graphic position="anchor" xlink:href="11302_2007_9064_Fig4_HTML" id="MO4"/></fig></p>
        <p>Because many standard mammalian expression systems endogenously express P2Y receptors clear-cut functional studies are difficult to perform. One exception is the 1321N1 human astrocytoma cell line which does not express P2Y receptors. However, transient expression of GPCR in 1321N1 cells is limited by low transfection efficiency and stable transfection of these cells is usually required. Heterologous expression of GPCR in yeast was initially established for large-scale purification of receptor proteins. These advances in the expression of heterologous GPCR in the yeast <italic>Saccharomyces cerevisiae</italic> have led to the development of sensitive and selective assays of ligand-induced GPCR activation (reviewed in [<xref ref-type="bibr" rid="CR49">49</xref>]). To facilitate a more systematic genetic analysis of GPCR function, e.g., by saturating random mutagenesis, we took advantage of a yeast expression system in which parts of the mammalian GPCR signaling system (GPCR and chimeric G protein) are linked to a modified yeast pheromone pathway (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>) [<xref ref-type="bibr" rid="CR50">50</xref>]. The coupling of receptor activity to the genetically engineered yeast pathway allows for rapid and economical screening of substance libraries and randomly modified receptor libraries. Functional studies in yeast may have an advantage especially for P2Y receptors because one can (at least partially) circumvent specific problems in working with nucleotide receptors (see above). Only two NTPDases (GDA1 and YND1/APY1) have been found within the entire yeast genome which are mainly expressed in the Golgi apparatus [<xref ref-type="bibr" rid="CR51">51</xref>]. Although conversion of nucleotides by nucleotidases and ectoapyrases occur also in yeast and one cannot exclude conversion of extracellular nucleotides by yeast enzymes, there is no endogenous plasma membrane P2Y receptor in yeast which can mediate and, therefore, interfere with transmembrane signaling of heterologously expressed P2Y receptors in yeast. We and others have successfully used this system for expression and functional study of P2Y<sub>12</sub> [<xref ref-type="bibr" rid="CR52">52</xref>], P2Y<sub>14</sub> [<xref ref-type="bibr" rid="CR53">53</xref>], and <italic>lyso</italic>-PS receptor GPR34 (unpublished data). As shown in Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>a, P2Y<sub>12</sub>-expressing yeast cells grow only in the presence of the agonist 2-methylthioadenosine 5&#x2032;-diphosphate (2MeS-ADP).
<fig id="Fig5"><label>Fig.&#xA0;5</label><caption><p>Functional expression and in vitro evolution of GPCR in yeast. Genetically modified yeast cells are transformed with a mammalian GPCR. Following agonist activation and constitutive receptor activity, the receptor couples to a chimeric G protein [backbone yeast G protein Gpa1 in which the C-terminal five amino acids were replaced by the respective mammalian G protein sequence (e.g., from the G<sub>i</sub> protein)]. Activation of the chimeric G protein enables yeast cells to grow on histidine-free medium by utilizing parts of the yeast mating pathway [<xref ref-type="bibr" rid="CR49">49</xref>]. <italic>Gpa</italic> yeast ortholog of the mammalian G protein alpha subunit, <italic>Ste4</italic> yeast ortholog of the mammalian G protein beta subunit, <italic>Ste18</italic> yeast ortholog of the mammalian G protein gamma subunit, <italic>Ste12</italic> transcription factor that is activated by a MAP kinase signaling cascade, <italic>Far1</italic> cell cycle regulator that directly inhibits the yeast cyclin-dependent kinase Cdc28-Cln</p></caption><graphic position="anchor" xlink:href="11302_2007_9064_Fig5_HTML" id="MO5"/></fig><fig id="Fig6"><label>Fig.&#xA0;6</label><caption><p>Functional expression and random mutagenesis of P2Y<sub>12</sub> in yeast. <bold>a</bold> The human P2Y<sub>12</sub> receptor was transformed into modified yeast (see Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>). The agonist 2-methylthioadenosine 5&#x2032;-diphosphate (2MeS-ADP) induces a robust yeast cell growth. <bold>b</bold> The entire coding region of the human P2Y<sub>12</sub> was subjected to random mutagenesis and transformed yeast cells were selected for growth in agonist-free U<sup>&#x2212;</sup>/H<sup>&#x2212;</sup>medium. Colonies that grow under this condition contain a constitutively active P2Y<sub>12</sub>. Exemplarily, mutations of a triple mutant (L<sup>115</sup>Q/F<sup>177</sup>S/R<sup>224</sup>G) were individualized and tested separately for constitutive activity. The data indicate that L<sup>115</sup>Q mainly contributes to the constitutive activity of the triple mutant</p></caption><graphic position="anchor" xlink:href="11302_2007_9064_Fig6_HTML" id="MO6"/></fig></p>
        <p>Constitutively active GPCR are useful tools in studying the action of inverse agonists and activation mechanisms in GPCR. A constitutively active P2Y<sub>12</sub> was generated by replacing the endogenous C terminus with the corresponding part of the human P2Y<sub>1</sub> receptor [<xref ref-type="bibr" rid="CR54">54</xref>]. Pharmacological evaluation of several P2Y<sub>12</sub> antagonists revealed AR-C78511 (an adenosine derivative) as a potent P2Y<sub>12</sub> inverse agonist. Traditional mutagenesis approaches are limited to screen for activating mutations because the number of mutant proteins that can be investigated is usually relatively small, primarily because of technical reasons and the time and costs needed to generate and analyze large numbers of mutant receptors. To circumvent these limitations, yeast has emerged as a highly useful host for the in vivo reconstitution of mammalian GPCR. Therefore, we applied a random mutagenesis and screening approach in yeast to identify key residues in maintaining ground stage of the human P2Y<sub>12</sub>. PCR-based random mutagenesis was optimized to induce approximately four mutations in 1&#xA0;kbp. Several dozen clones were selected and are now under in-depth investigation. For example, we identified a triple mutant P2Y<sub>12</sub> (Leu<sup>115</sup>Gln/Phe<sup>177</sup>Ser/Arg<sup>224</sup>Gly), and individual characterization revealed Leu<sup>115</sup>Gln (TMD3) to be mainly responsible for constitutive activity in the yeast expression system (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>b). These promising results in applying the yeast expression system await further efforts to identify functionally relevant determinants in P2Y<sub>12</sub>-like receptors.</p>
      </sec>
      <sec id="Sec9">
        <title>Establishing in vivo function of P2Y<sub>12</sub>-like receptors using mouse models</title>
        <p>Selective receptor ligand and receptor-deficient animal models are suitable tools to evaluate the physiological relevance of distinct GPCR. Enormous efforts have been undertaken in the development of selective and clinically useful ADP and other nucleotide receptor ligands. But except for P2Y<sub>12</sub>, dissection of the physiological relevance of all other P2Y<sub>12</sub>-like GPCR is at the very early stage. Since the pharmacological properties of ligands have been reviewed in detail elsewhere [<xref ref-type="bibr" rid="CR2">2</xref>] we only shortly summarize available data on receptor-deficient animal models.</p>
        <p>Based on the clinical success of irreversibly bound P2Y<sub>12</sub> antagonists, such as clopidogrel, the pivotal role of ADP in arterial thrombogenesis is well established. Although the combined action of P2Y<sub>1</sub> and P2Y<sub>12</sub> is necessary for the full platelet aggregation response to ADP, mice deficient for P2Y<sub>12</sub> already display reduced platelet adhesion/activation, thrombus growth, and stability [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. Except for the altered platelet functionality P2Y<sub>12</sub>-deficient mice appear normal under standard laboratory conditions. In consent with this finding, we occasionally identified a frameshift (T insertion at base pair position 667) in the P2Y<sub>12</sub> coding sequence of several individuals of the Asian house mouse (inbred laboratory strain of <italic>Mus musculus castaneus</italic> from of the Laboratoire G&#xE9;nome Populations Interactions Adaptation at the Universite Montpellier, France) during ortholog screening which showed no obvious phenotype in standard laboratory captivity. The platelet function was, however, not tested. The identified P2Y<sub>12</sub> inactivation in some Asian house mice may reflect either natural polymorphisms present in the wild population or a new polymorphism that has been introduced during captivity. To distinguish between these possibilities, we analyzed the position 667 in P2Y<sub>12</sub> from 88 wild <italic>M. m. castaneus</italic> trapped in Taiwan [<xref ref-type="bibr" rid="CR41">41</xref>]. All contained the intact P2Y<sub>12</sub> allele indicating that the inactive P2Y<sub>12</sub> allele is very rare or absent in this wild <italic>M. m. castaneus</italic> population and favors the hypothesis of its acquisition in captivity (unpublished observations).</p>
        <p>The fact that receptor deficiency is per se compatible with viability and fertility appears to be true also for other P2Y<sub>12</sub>-like receptor-deficient species and mouse models. For example, mice individually lacking GPR82 and GPR34 are viable, fertile, and produced viable offspring (own unpublished observation). Further, there are several vertebrate classes and species naturally deficient in distinct P2Y<sub>12</sub>-like receptors. For example, P2Y<sub>13</sub> is absent in fish genomes sequenced so far, GPR82 is not present in pufferfish genomes, and GPR171 is absent in pufferfish and <italic>Xenopus</italic> genomes.</p>
        <p>It appears that many functions of P2Y<sub>12</sub>-like receptors are more distinct and their disclosure requires specific challenging conditions. Indeed, P2Y<sub>12</sub>-deficient mice revealed an unexpected phenotype when specifically challenged. CNS injury is accompanied by release of nucleotides, serving as signals for microglial activation or chemotaxis. Microglia cells express several purinoceptors, including P2Y<sub>12</sub>. Microglia in P2Y<sub>12</sub>-deficient mice showed significantly diminished directional branch extension toward sites of cortical damage in the living mouse. These results imply that P2Y<sub>12</sub> is a primary site at which nucleotides act to induce microglial chemotaxis at early stages of the response to local CNS injury [<xref ref-type="bibr" rid="CR56">56</xref>].</p>
      </sec>
      <sec id="Sec10">
        <title>Variants of P2Y<sub>12</sub>-like receptor genes within human populations</title>
        <p>Activating and inactivating mutations in GPCR have been made responsible for more than 30 different human diseases [<xref ref-type="bibr" rid="CR57">57</xref>]. As expected from its pivotal role in platelet activation inactivating mutations in P2Y<sub>12</sub> can cause a congenital bleeding disorder. Only a few missense (Met<sup>1</sup>Arg, Pro<sup>258</sup>Thr, Arg<sup>256</sup>Gln, Arg<sup>265</sup>Trp) and frameshifting (frameshift at amino acid position 240) mutations have been reported [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR58">58</xref>&#x2013;<xref ref-type="bibr" rid="CR60">60</xref>]. Unexceptionally, the missense mutations found are at highly conserved positions and cause an impairment of receptor function. There are no other human diseases identified yet which are associated with dysfunction of P2Y<sub>12</sub>-like receptors.</p>
        <p>The antithrombotic effect of clopidogrel is considerably variable and the P2Y<sub>12</sub> gene was screened for possible sequence variants. Five nucleotide variations were found in the human P2Y<sub>12</sub> gene, two of them silent substitutions in the coding region [<xref ref-type="bibr" rid="CR61">61</xref>]. Several studies were initiated to investigate the impact of P2Y<sub>12</sub> polymorphisms on atherosclerosis [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>] and clopidogrel efficiency in preventing neurological events [<xref ref-type="bibr" rid="CR64">64</xref>] showing no or some association to one haplotype. In single nucleotide polymorphism (SNP) projects, such as HapMap [<xref ref-type="bibr" rid="CR65">65</xref>], SeattleSNP etc., silent variations have been identified at amino acid position Val<sup>4</sup>, Asn<sup>6</sup>, Gly<sup>12</sup>, and Phe<sup>182</sup> of P2Y<sub>12</sub>. For example the C/T variation at amino acid position Phe<sup>182</sup> is only found in the African population whereas the G/T variation at position Gly<sup>12</sup> is present only in European and Asian populations. One missense mutation (Glu<sup>330</sup>Gly; receptor C terminus) has been detected in SNP projects. This variant is absent in European and Asian populations but displays an allelic frequency of about 15% in the African population. The functional relevance of this missense mutation has not been studied yet but a Gly at position 330 is naturally found in many other P2Y<sub>12</sub> orthologs including primate P2Y<sub>12</sub> almost ruling out a specific input in receptor function.</p>
        <p>One silent variant (C/T at Ile<sup>59</sup>) and one substituting variant (T/C at Met<sup>158</sup>Thr) were identified in the coding region of P2Y<sub>13</sub>. The Thr<sup>158</sup> variant is less frequent in African populations (~4%) when compared to European (~21%) and Asian (~18%) populations. Met<sup>158</sup> is not conserved and a Thr at this position is found in the dolphin (<italic>Tursiops truncates</italic>).</p>
        <p>Only two silent substitutions (A/G at Ala<sup>35</sup> and T/C at Phe<sup>240</sup>) have been identified in P2Y<sub>14</sub> so far. The GPR171 gene contains two more frequent silent substitutions (T/C at Tyr<sup>19</sup>, A/C Thr<sup>58</sup>) and one missense variant (A/G at Ile<sup>283</sup>Val, frequency about 6%) which is located within the DPXXY motif of TMD7. Ile<sup>283</sup> is quite conserved among vertebrate GPR171 orthologs. The functional relevance of Val<sup>283</sup> has not been studied yet but it occurs naturally in the zebrafish ortholog.</p>
        <p>In the human GPR87 gene three silent polymorphisms (G/A at Pro<sup>46</sup>, G/A at Leu<sup>179</sup>, C/T at Tyr<sup>355</sup>) and one nonsynonymous polymorphism (C/T at Thr<sup>205</sup>Met) are present. The position 205 is not conserved and Met<sup>205</sup> is found in several rodents. Only rare silent substitutions in the coding regions have been found in GPR82 (C/T at Asp<sup>313</sup>) and in GPR34 (A/G at Val<sup>296</sup>) [<xref ref-type="bibr" rid="CR34">34</xref>].</p>
        <p>SNP stochastically occur in individual genomes and can amount to a reasonable frequency in populations by drift but also by selection. There are several approaches and methods which are suitable to distinguish between drift and selection. Population genetic models predict that selection can leave &#x201C;footprints&#x201D; in closely linked genomic regions. Several methods were developed to detect signatures of selective sweeps in genomic sequences [<xref ref-type="bibr" rid="CR66">66</xref>]. All methods require data on allele variation (mainly SNP) within populations. Large genome-wide analyses have scanned the human genome for signatures of positive selection on the basis of nonsynonymous and synonymous substitution ratios or single nucleotide polymorphism (SNP) data. Several loci which contain GPCR genes have been identified using such methods, but the P2Y<sub>12</sub>-like receptor-containing loci showed no strong signatures of recent positive selection in these studies [<xref ref-type="bibr" rid="CR67">67</xref>&#x2013;<xref ref-type="bibr" rid="CR70">70</xref>].</p>
      </sec>
    </sec>
    <sec id="Sec11" sec-type="conclusion">
      <title>Conclusion</title>
      <p>P2Y<sub>12</sub>-like receptors which are grouped mainly by phylogenetic relations have been an inherent part of the vertebrate GPCR repertoire since more than 450 Myr. Although sharing features in respect to structural determinants and signal transduction the activating ligands are heterogeneous such as nucleotides, nucleotide derivatives, leukotrienes, and phospholipids. We are at the very beginning of understanding the physiological importance of the individual members. The nature of the ligands, first functional data, and expression of several members in migrating cells point at functions in immunologic response and tissue damage response. Doubtless, upcoming receptor-deficient mouse models and selective receptor ligands will help to unveil the functions of P2Y<sub>12</sub>-like receptor members. Further, one should consider combined receptor-deficient mouse models within this group but also with other P2Y receptors to uncover phenotypes which are hidden by receptor redundancy, e.g., in the case of ADP receptors.</p>
    </sec>
  </body>
  <back>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fredriksson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lagerstrom</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Lundin</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Schioth</surname>
              <given-names>HB</given-names>
            </name>
          </person-group>
          <article-title>The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints</article-title>
          <source>Mol Pharmacol</source>
          <year>2003</year>
          <volume>63</volume>
          <issue>6</issue>
          <fpage>1256</fpage>
          <lpage>1272</lpage>
          <pub-id pub-id-type="doi">10.1124/mol.63.6.1256</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB (2003) The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63(6):1256&#x2013;1272 <pub-id pub-id-type="pmid">12761335</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kugelgen</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Pharmacological profiles of cloned mammalian P2Y-receptor subtypes</article-title>
          <source>Pharmacol Ther</source>
          <year>2006</year>
          <volume>110</volume>
          <issue>3</issue>
          <fpage>415</fpage>
          <lpage>432</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pharmthera.2005.08.014</pub-id>
        </citation>
        <citation citation-type="display-unstructured">von Kugelgen I (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110(3):415&#x2013;432 <pub-id pub-id-type="pmid">16257449</pub-id></citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jacobson</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Costanzi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ohno</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular recognition at purine and pyrimidine nucleotide (P2) receptors</article-title>
          <source>Curr Top Med Chem</source>
          <year>2004</year>
          <volume>4</volume>
          <issue>8</issue>
          <fpage>805</fpage>
          <lpage>819</lpage>
          <pub-id pub-id-type="doi">10.2174/1568026043450961</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Jacobson KA, Costanzi S, Ohno M et al (2004) Molecular recognition at purine and pyrimidine nucleotide (P2) receptors. Curr Top Med Chem 4(8):805&#x2013;819 <pub-id pub-id-type="pmid">15078212</pub-id></citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>King</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Townsend-Nicholson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Metabotropic receptors for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors</article-title>
          <source>Trends Pharmacol Sci</source>
          <year>1998</year>
          <volume>19</volume>
          <issue>12</issue>
          <fpage>506</fpage>
          <lpage>514</lpage>
          <pub-id pub-id-type="doi">10.1016/S0165-6147(98)01271-1</pub-id>
        </citation>
        <citation citation-type="display-unstructured">King BF, Townsend-Nicholson A, Burnstock G (1998) Metabotropic receptors for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors. Trends Pharmacol Sci 19(12):506&#x2013;514 <pub-id pub-id-type="pmid">9871413</pub-id></citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harden</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Lazarowski</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Boucher</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Release, metabolism and interconversion of adenine and uridine nucleotides: implications for G protein-coupled P2 receptor agonist selectivity</article-title>
          <source>Trends Pharmacol Sci</source>
          <year>1997</year>
          <volume>18</volume>
          <issue>2</issue>
          <fpage>43</fpage>
          <lpage>46</lpage>
        </citation>
        <citation citation-type="display-unstructured">Harden TK, Lazarowski ER, Boucher RC (1997) Release, metabolism and interconversion of adenine and uridine nucleotides: implications for G protein-coupled P2 receptor agonist selectivity. Trends Pharmacol Sci 18(2):43&#x2013;46 <pub-id pub-id-type="pmid">9090307</pub-id></citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akbar</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Dasari</surname>
              <given-names>VR</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>TE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells</article-title>
          <source>J Biol Chem</source>
          <year>1996</year>
          <volume>271</volume>
          <issue>31</issue>
          <fpage>18363</fpage>
          <lpage>18367</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.271.31.18363</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Akbar GK, Dasari VR, Webb TE et al (1996) Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells. J Biol Chem 271(31):18363&#x2013;18367 <pub-id pub-id-type="pmid">8702478</pub-id></citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Schachter</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Harden</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Nicholas</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>The 6H1 orphan receptor, claimed to be the p2y5 receptor, does not mediate nucleotide-promoted second messenger responses</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>1997</year>
          <volume>236</volume>
          <issue>2</issue>
          <fpage>455</fpage>
          <lpage>460</lpage>
          <pub-id pub-id-type="doi">10.1006/bbrc.1997.6984</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Li Q, Schachter JB, Harden TK, Nicholas RA (1997) The 6H1 orphan receptor, claimed to be the p2y5 receptor, does not mediate nucleotide-promoted second messenger responses. Biochem Biophys Res Commun 236(2):455&#x2013;460 <pub-id pub-id-type="pmid">9240460</pub-id></citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Webb</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Barnard</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>Identification of 6H1 as a P2Y purinoceptor: P2Y5</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>1996</year>
          <volume>219</volume>
          <issue>1</issue>
          <fpage>105</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="doi">10.1006/bbrc.1996.0189</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Webb TE, Kaplan MG, Barnard EA (1996) Identification of 6H1 as a P2Y purinoceptor: P2Y5. Biochem Biophys Res Commun 219(1):105&#x2013;110 <pub-id pub-id-type="pmid">8619790</pub-id></citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yokomizo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Terawaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Izumi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders</article-title>
          <source>J Exp Med</source>
          <year>2000</year>
          <volume>192</volume>
          <issue>3</issue>
          <fpage>421</fpage>
          <lpage>432</lpage>
          <pub-id pub-id-type="doi">10.1084/jem.192.3.421</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Yokomizo T, Kato K, Terawaki K, Izumi T, Shimizu T (2000) A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med 192(3):421&#x2013;432 <pub-id pub-id-type="pmid">10934230</pub-id></citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <citation citation-type="other">Joost P, Methner A (2002) Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands. Genome Biol 3(11):RESEARCH0063</citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nonaka</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hiramoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2005</year>
          <volume>337</volume>
          <issue>1</issue>
          <fpage>281</fpage>
          <lpage>288</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbrc.2005.09.052</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Nonaka Y, Hiramoto T, Fujita N (2005) Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods. Biochem Biophys Res Commun 337(1):281&#x2013;288 <pub-id pub-id-type="pmid">16185654</pub-id></citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mellor</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Frank</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Soler</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: functional distinction from CysLT1R</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2003</year>
          <volume>100</volume>
          <issue>20</issue>
          <fpage>11589</fpage>
          <lpage>11593</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.2034927100</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Mellor EA, Frank N, Soler D et al (2003) Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: functional distinction from CysLT1R. Proc Natl Acad Sci USA 100(20):11589&#x2013;11593 <pub-id pub-id-type="pmid">13679572</pub-id></citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mellor</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Maekawa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Austen</surname>
              <given-names>KF</given-names>
            </name>
            <name>
              <surname>Boyce</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2001</year>
          <volume>98</volume>
          <issue>14</issue>
          <fpage>7964</fpage>
          <lpage>7969</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.141221498</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Mellor EA, Maekawa A, Austen KF, Boyce JA (2001) Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc Natl Acad Sci USA 98(14):7964&#x2013;7969 <pub-id pub-id-type="pmid">11438743</pub-id></citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mamedova</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Capra</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Accomazzo</surname>
              <given-names>MR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors</article-title>
          <source>Biochem Pharmacol</source>
          <year>2005</year>
          <volume>71</volume>
          <issue>1&#x2013;2</issue>
          <fpage>115</fpage>
          <lpage>125</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bcp.2005.10.003</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Mamedova L, Capra V, Accomazzo MR et al (2005) CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors. Biochem Pharmacol 71(1&#x2013;2):115&#x2013;125 <pub-id pub-id-type="pmid">16280122</pub-id></citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nomura</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Miyajima</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sazuka</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1</article-title>
          <source>DNA Res</source>
          <year>1994</year>
          <volume>1</volume>
          <issue>1</issue>
          <fpage>27</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="doi">10.1093/dnares/1.1.27</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Nomura N, Miyajima N, Sazuka T et al (1994) Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1. DNA Res 1(1):27&#x2013;35 <pub-id pub-id-type="pmid">7584026</pub-id></citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Charlton</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Fogliano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sweetnam</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Duman</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>The isolation and characterization of a novel G protein-coupled receptor regulated by immunologic challenge</article-title>
          <source>Brain Res</source>
          <year>1997</year>
          <volume>764</volume>
          <issue>1&#x2013;2</issue>
          <fpage>141</fpage>
          <lpage>148</lpage>
          <pub-id pub-id-type="doi">10.1016/S0006-8993(97)00438-1</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Charlton ME, Williams AS, Fogliano M, Sweetnam PM, Duman RS (1997) The isolation and characterization of a novel G protein-coupled receptor regulated by immunologic challenge. Brain Res 764(1&#x2013;2):141&#x2013;148 <pub-id pub-id-type="pmid">9295203</pub-id></citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chambers</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Macdonald</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Sarau</surname>
              <given-names>HM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A G protein-coupled receptor for UDP-glucose</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <issue>15</issue>
          <fpage>10767</fpage>
          <lpage>10771</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.275.15.10767</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Chambers JK, Macdonald LE, Sarau HM et al (2000) A G protein-coupled receptor for UDP-glucose. J Biol Chem 275(15):10767&#x2013;10771 <pub-id pub-id-type="pmid">10753868</pub-id></citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Foster</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Prosser</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Agans</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs</article-title>
          <source>J Clin Invest</source>
          <year>2001</year>
          <volume>107</volume>
          <issue>12</issue>
          <fpage>1591</fpage>
          <lpage>1598</lpage>
        </citation>
        <citation citation-type="display-unstructured">Foster CJ, Prosser DM, Agans JM et al (2001) Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 107(12):1591&#x2013;1598 <pub-id pub-id-type="pmid">11413167</pub-id></citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hollopeter</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Jantzen</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Vincent</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of the platelet ADP receptor targeted by antithrombotic drugs</article-title>
          <source>Nature</source>
          <year>2001</year>
          <volume>409</volume>
          <issue>6817</issue>
          <fpage>202</fpage>
          <lpage>207</lpage>
          <pub-id pub-id-type="doi">10.1038/35051599</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Hollopeter G, Jantzen HM, Vincent D et al (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409(6817):202&#x2013;207 <pub-id pub-id-type="pmid">11196645</pub-id></citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takasaki</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kamohara</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor</article-title>
          <source>Mol Pharmacol</source>
          <year>2001</year>
          <volume>60</volume>
          <issue>3</issue>
          <fpage>432</fpage>
          <lpage>439</lpage>
        </citation>
        <citation citation-type="display-unstructured">Takasaki J, Kamohara M, Saito T et al (2001) Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor. Mol Pharmacol 60(3):432&#x2013;439 <pub-id pub-id-type="pmid">11502873</pub-id></citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gustafson</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <issue>11</issue>
          <fpage>8608</fpage>
          <lpage>8615</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M009718200</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Zhang FL, Luo L, Gustafson E et al (2001) ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J Biol Chem 276(11):8608&#x2013;8615 <pub-id pub-id-type="pmid">11104774</pub-id></citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Communi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Detheux</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of a novel human ADP receptor coupled to G(i)</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <issue>44</issue>
          <fpage>41479</fpage>
          <lpage>41485</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M105912200</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Communi D, Gonzalez NS, Detheux M et al (2001) Identification of a novel human ADP receptor coupled to G(i). J Biol Chem 276(44):41479&#x2013;41485 <pub-id pub-id-type="pmid">11546776</pub-id></citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gustafson</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2Y(13): identification and characterization of a novel Galphai-coupled ADP receptor from human and mouse</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>2002</year>
          <volume>301</volume>
          <issue>2</issue>
          <fpage>705</fpage>
          <lpage>713</lpage>
          <pub-id pub-id-type="doi">10.1124/jpet.301.2.705</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Zhang FL, Luo L, Gustafson E et al (2002) P2Y(13): identification and characterization of a novel Galphai-coupled ADP receptor from human and mouse. J Pharmacol Exp Ther 301(2):705&#x2013;713 <pub-id pub-id-type="pmid">11961076</pub-id></citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marteau</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Le Poul</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Communi</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pharmacological characterization of the human P2Y13 receptor</article-title>
          <source>Mol Pharmacol</source>
          <year>2003</year>
          <volume>64</volume>
          <issue>1</issue>
          <fpage>104</fpage>
          <lpage>112</lpage>
          <pub-id pub-id-type="doi">10.1124/mol.64.1.104</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Marteau F, Le Poul E, Communi D et al (2003) Pharmacological characterization of the human P2Y13 receptor. Mol Pharmacol 64(1):104&#x2013;112 <pub-id pub-id-type="pmid">12815166</pub-id></citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chhatriwala</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ravi</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>RI</given-names>
            </name>
            <name>
              <surname>Boyer</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Harden</surname>
              <given-names>TK</given-names>
            </name>
          </person-group>
          <article-title>Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>2004</year>
          <volume>311</volume>
          <issue>3</issue>
          <fpage>1038</fpage>
          <lpage>1043</lpage>
          <pub-id pub-id-type="doi">10.1124/jpet.104.068650</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Chhatriwala M, Ravi RG, Patel RI, Boyer JL, Jacobson KA, Harden TK (2004) Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog. J Pharmacol Exp Ther 311(3):1038&#x2013;1043 <pub-id pub-id-type="pmid">15345752</pub-id></citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marchese</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sawzdargo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Discovery of three novel orphan G-protein-coupled receptors</article-title>
          <source>Genomics</source>
          <year>1999</year>
          <volume>56</volume>
          <issue>1</issue>
          <fpage>12</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1006/geno.1998.5655</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Marchese A, Sawzdargo M, Nguyen T et al (1999) Discovery of three novel orphan G-protein-coupled receptors. Genomics 56(1):12&#x2013;21 <pub-id pub-id-type="pmid">10036181</pub-id></citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schoneberg</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Grosse</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel subgroup of class I G-protein-coupled receptors</article-title>
          <source>Biochim Biophys Acta</source>
          <year>1999</year>
          <volume>1446</volume>
          <issue>1&#x2013;2</issue>
          <fpage>57</fpage>
          <lpage>70</lpage>
        </citation>
        <citation citation-type="display-unstructured">Schoneberg T, Schulz A, Grosse R et al (1999) A novel subgroup of class I G-protein-coupled receptors. Biochim Biophys Acta 1446(1&#x2013;2):57&#x2013;70 <pub-id pub-id-type="pmid">10395919</pub-id></citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>KR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Discovery and mapping of ten novel G protein-coupled receptor genes</article-title>
          <source>Gene</source>
          <year>2001</year>
          <volume>275</volume>
          <issue>1</issue>
          <fpage>83</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="doi">10.1016/S0378-1119(01)00651-5</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Lee DK, Nguyen T, Lynch KR et al (2001) Discovery and mapping of ten novel G protein-coupled receptor genes. Gene 275(1):83&#x2013;91 <pub-id pub-id-type="pmid">11574155</pub-id></citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wittenberger</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schaller</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Hellebrand</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors</article-title>
          <source>J Mol Biol</source>
          <year>2001</year>
          <volume>307</volume>
          <issue>3</issue>
          <fpage>799</fpage>
          <lpage>813</lpage>
          <pub-id pub-id-type="doi">10.1006/jmbi.2001.4520</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Wittenberger T, Schaller HC, Hellebrand S (2001) An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors. J Mol Biol 307(3):799&#x2013;813 <pub-id pub-id-type="pmid">11273702</pub-id></citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jacobs</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Collins-Racie</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Colbert</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A genetic selection for isolating cDNAs encoding secreted proteins</article-title>
          <source>Gene</source>
          <year>1997</year>
          <volume>198</volume>
          <issue>1&#x2013;2</issue>
          <fpage>289</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="doi">10.1016/S0378-1119(97)00330-2</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Jacobs KA, Collins-Racie LA, Colbert M et al (1997) A genetic selection for isolating cDNAs encoding secreted proteins. Gene 198(1&#x2013;2):289&#x2013;296 <pub-id pub-id-type="pmid">9370294</pub-id></citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sugo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tachimoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chikatsu</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of a lysophosphatidylserine receptor on mast cells</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2006</year>
          <volume>341</volume>
          <issue>4</issue>
          <fpage>1078</fpage>
          <lpage>1087</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbrc.2006.01.069</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Sugo T, Tachimoto H, Chikatsu T et al (2006) Identification of a lysophosphatidylserine receptor on mast cells. Biochem Biophys Res Commun 341(4):1078&#x2013;1087 <pub-id pub-id-type="pmid">16460680</pub-id></citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mombaerts</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>The human repertoire of odorant receptor genes and pseudogenes</article-title>
          <source>Annu Rev Genomics Hum Genet</source>
          <year>2001</year>
          <volume>2</volume>
          <fpage>493</fpage>
          <lpage>510</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.genom.2.1.493</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Mombaerts P (2001) The human repertoire of odorant receptor genes and pseudogenes. Annu Rev Genomics Hum Genet 2:493&#x2013;510 <pub-id pub-id-type="pmid">11701659</pub-id></citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schulz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schoneberg</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The structural evolution of a P2Y-like G-protein-coupled receptor</article-title>
          <source>J Biol Chem</source>
          <year>2003</year>
          <volume>278</volume>
          <issue>37</issue>
          <fpage>35531</fpage>
          <lpage>35541</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M303346200</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Schulz A, Schoneberg T (2003) The structural evolution of a P2Y-like G-protein-coupled receptor. J Biol Chem 278(37):35531&#x2013;35541 <pub-id pub-id-type="pmid">12835326</pub-id></citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engemaier</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rompler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schoneberg</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Genomic and supragenomic structure of the nucleotide-like G-protein-coupled receptor GPR34</article-title>
          <source>Genomics</source>
          <year>2006</year>
          <volume>87</volume>
          <issue>2</issue>
          <fpage>254</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ygeno.2005.10.001</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Engemaier E, Rompler H, Schoneberg T, Schulz A (2006) Genomic and supragenomic structure of the nucleotide-like G-protein-coupled receptor GPR34. Genomics 87(2):254&#x2013;264 <pub-id pub-id-type="pmid">16338117</pub-id></citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roy</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Gilbert</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>The evolution of spliceosomal introns: patterns, puzzles and progress</article-title>
          <source>Nat Rev Genet</source>
          <year>2006</year>
          <volume>7</volume>
          <issue>3</issue>
          <fpage>211</fpage>
          <lpage>221</lpage>
        </citation>
        <citation citation-type="display-unstructured">Roy SW, Gilbert W (2006) The evolution of spliceosomal introns: patterns, puzzles and progress. Nat Rev Genet 7(3):211&#x2013;221 <pub-id pub-id-type="pmid">16485020</pub-id></citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Song</surname>
              <given-names>KY</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>CS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Translational repression of mouse mu opioid receptor expression via leaky scanning</article-title>
          <source>Nucleic Acids Res</source>
          <year>2007</year>
          <volume>35</volume>
          <issue>5</issue>
          <fpage>1501</fpage>
          <lpage>1513</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkm034</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Song KY, Hwang CK, Kim CS et al (2007) Translational repression of mouse mu opioid receptor expression via leaky scanning. Nucleic Acids Res 35(5):1501&#x2013;1513 <pub-id pub-id-type="pmid">17284463</pub-id></citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rabadan-Diehl</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Volpi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Subburaju</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Aguilera</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of vasopressin V1b receptor translation by upstream open reading frames in the 5&#x2032;-untranslated region</article-title>
          <source>J Neuroendocrinol</source>
          <year>2007</year>
          <volume>19</volume>
          <issue>4</issue>
          <fpage>309</fpage>
          <lpage>319</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2826.2007.01533.x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Rabadan-Diehl C, Martinez A, Volpi S, Subburaju S, Aguilera G (2007) Inhibition of vasopressin V1b receptor translation by upstream open reading frames in the 5&#x2032;-untranslated region. J Neuroendocrinol 19(4):309&#x2013;319 <pub-id pub-id-type="pmid">17355321</pub-id></citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abbracchio</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Boeynaems</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Barnard</surname>
              <given-names>EA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family</article-title>
          <source>Trends Pharmacol Sci</source>
          <year>2003</year>
          <volume>24</volume>
          <issue>2</issue>
          <fpage>52</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="doi">10.1016/S0165-6147(02)00038-X</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Abbracchio MP, Boeynaems JM, Barnard EA et al (2003) Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 24(2):52&#x2013;55 <pub-id pub-id-type="pmid">12559763</pub-id></citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Costanzi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mamedova</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>ZG</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling</article-title>
          <source>J Med Chem</source>
          <year>2004</year>
          <volume>47</volume>
          <issue>22</issue>
          <fpage>5393</fpage>
          <lpage>5404</lpage>
          <pub-id pub-id-type="doi">10.1021/jm049914c</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Costanzi S, Mamedova L, Gao ZG, Jacobson KA (2004) Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. J Med Chem 47(22):5393&#x2013;5404 <pub-id pub-id-type="pmid">15481977</pub-id></citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rompler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pitra</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The rise and fall of the chemoattractant receptor GPR33</article-title>
          <source>J Biol Chem</source>
          <year>2005</year>
          <volume>280</volume>
          <issue>35</issue>
          <fpage>31068</fpage>
          <lpage>31075</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M503586200</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Rompler H, Schulz A, Pitra C et al (2005) The rise and fall of the chemoattractant receptor GPR33. J Biol Chem 280(35):31068&#x2013;31075 <pub-id pub-id-type="pmid">15987686</pub-id></citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rompler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Arnold</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Orth</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schoneberg</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Functional consequences of naturally occurring DRY motif variants in the mammalian chemoattractant receptor GPR33</article-title>
          <source>Genomics</source>
          <year>2006</year>
          <volume>87</volume>
          <issue>6</issue>
          <fpage>724</fpage>
          <lpage>732</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ygeno.2006.02.009</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Rompler H, Yu HT, Arnold A, Orth A, Schoneberg T (2006) Functional consequences of naturally occurring DRY motif variants in the mammalian chemoattractant receptor GPR33. Genomics 87(6):724&#x2013;732 <pub-id pub-id-type="pmid">16595170</pub-id></citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sangkuhl</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rompler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Busch</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Karges</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Schoneberg</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Nephrogenic diabetes insipidus caused by mutation of Tyr205: a key residue of V2 vasopressin receptor function</article-title>
          <source>Hum Mutat</source>
          <year>2005</year>
          <volume>25</volume>
          <issue>5</issue>
          <fpage>505</fpage>
          <pub-id pub-id-type="doi">10.1002/humu.9337</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Sangkuhl K, Rompler H, Busch W, Karges B, Schoneberg T (2005) Nephrogenic diabetes insipidus caused by mutation of Tyr205: a key residue of V2 vasopressin receptor function. Hum Mutat 25(5):505 <pub-id pub-id-type="pmid">15841479</pub-id></citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muller</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bayer</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Myrtek</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The P2Y14 receptor of airway epithelial cells: coupling to intracellular Ca2+ and IL-8 secretion</article-title>
          <source>Am J Respir Cell Mol Biol</source>
          <year>2005</year>
          <volume>33</volume>
          <issue>6</issue>
          <fpage>601</fpage>
          <lpage>609</lpage>
          <pub-id pub-id-type="doi">10.1165/rcmb.2005-0181OC</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Muller T, Bayer H, Myrtek D et al (2005) The P2Y14 receptor of airway epithelial cells: coupling to intracellular Ca2+ and IL-8 secretion. Am J Respir Cell Mol Biol 33(6):601&#x2013;609 <pub-id pub-id-type="pmid">16109883</pub-id></citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Offermanns</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>MI</given-names>
            </name>
          </person-group>
          <article-title>G alpha 15 and G alpha 16 couple a wide variety of receptors to phospholipase C</article-title>
          <source>J Biol Chem</source>
          <year>1995</year>
          <volume>270</volume>
          <issue>25</issue>
          <fpage>15175</fpage>
          <lpage>15180</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.270.25.15175</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Offermanns S, Simon MI (1995) G alpha 15 and G alpha 16 couple a wide variety of receptors to phospholipase C. J Biol Chem 270(25):15175&#x2013;15180 <pub-id pub-id-type="pmid">7797501</pub-id></citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fumagalli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Trincavelli</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lecca</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Martini</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ciana</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Abbracchio</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Cloning, pharmacological characterisation and distribution of the rat G-protein-coupled P2Y(13) receptor</article-title>
          <source>Biochem Pharmacol</source>
          <year>2004</year>
          <volume>68</volume>
          <issue>1</issue>
          <fpage>113</fpage>
          <lpage>124</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bcp.2004.02.038</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Fumagalli M, Trincavelli L, Lecca D, Martini C, Ciana P, Abbracchio MP (2004) Cloning, pharmacological characterisation and distribution of the rat G-protein-coupled P2Y(13) receptor. Biochem Pharmacol 68(1):113&#x2013;124 <pub-id pub-id-type="pmid">15183123</pub-id></citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kostenis</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Waelbroeck</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Milligan</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Techniques: promiscuous Galpha proteins in basic research and drug discovery</article-title>
          <source>Trends Pharmacol Sci</source>
          <year>2005</year>
          <volume>26</volume>
          <issue>11</issue>
          <fpage>595</fpage>
          <lpage>602</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tips.2005.09.007</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Kostenis E, Waelbroeck M, Milligan G (2005) Techniques: promiscuous Galpha proteins in basic research and drug discovery. Trends Pharmacol Sci 26(11):595&#x2013;602 <pub-id pub-id-type="pmid">16183138</pub-id></citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conklin</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Farfel</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Lustig</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Julius</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bourne</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha</article-title>
          <source>Nature</source>
          <year>1993</year>
          <volume>363</volume>
          <issue>6426</issue>
          <fpage>274</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="doi">10.1038/363274a0</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Conklin BR, Farfel Z, Lustig KD, Julius D, Bourne HR (1993) Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha. Nature 363(6426):274&#x2013;276 <pub-id pub-id-type="pmid">8387644</pub-id></citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ko</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fricks</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ivanov</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Harden</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Structure-activity relationship of uridine 5&#x2032;-diphosphoglucose analogues as agonists of the human P2Y14 receptor</article-title>
          <source>J Med Chem</source>
          <year>2007</year>
          <volume>50</volume>
          <issue>9</issue>
          <fpage>2030</fpage>
          <lpage>2039</lpage>
          <pub-id pub-id-type="doi">10.1021/jm061222w</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Ko H, Fricks I, Ivanov AA, Harden TK, Jacobson KA (2007) Structure-activity relationship of uridine 5&#x2032;-diphosphoglucose analogues as agonists of the human P2Y14 receptor. J Med Chem 50(9):2030&#x2013;2039 <pub-id pub-id-type="pmid">17407275</pub-id></citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pausch</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>G-protein-coupled receptors in Saccharomyces cerevisiae: high-throughput screening assays for drug discovery</article-title>
          <source>Trends Biotechnol</source>
          <year>1997</year>
          <volume>15</volume>
          <issue>12</issue>
          <fpage>487</fpage>
          <lpage>494</lpage>
          <pub-id pub-id-type="doi">10.1016/S0167-7799(97)01119-0</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Pausch MH (1997) G-protein-coupled receptors in Saccharomyces cerevisiae: high-throughput screening assays for drug discovery. Trends Biotechnol 15(12):487&#x2013;494 <pub-id pub-id-type="pmid">9418303</pub-id></citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Price</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Kajkowski</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Hadcock</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Ozenberger</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Pausch</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>Functional coupling of a mammalian somatostatin receptor to the yeast pheromone response pathway</article-title>
          <source>Mol Cell Biol</source>
          <year>1995</year>
          <volume>15</volume>
          <issue>11</issue>
          <fpage>6188</fpage>
          <lpage>6195</lpage>
        </citation>
        <citation citation-type="display-unstructured">Price LA, Kajkowski EM, Hadcock JR, Ozenberger BA, Pausch MH (1995) Functional coupling of a mammalian somatostatin receptor to the yeast pheromone response pathway. Mol Cell Biol 15(11):6188&#x2013;6195 <pub-id pub-id-type="pmid">7565771</pub-id></citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhong</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Malhotra</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Guidotti</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Regulation of yeast ectoapyrase ynd1p activity by activator subunit Vma13p of vacuolar H+-ATPase</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <issue>45</issue>
          <fpage>35592</fpage>
          <lpage>35599</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M006932200</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Zhong X, Malhotra R, Guidotti G (2000) Regulation of yeast ectoapyrase ynd1p activity by activator subunit Vma13p of vacuolar H+-ATPase. J Biol Chem 275(45):35592&#x2013;35599 <pub-id pub-id-type="pmid">10954728</pub-id></citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pausch</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tseng</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Paulsen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bates</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kwak</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Functional expression of human and mouse P2Y12 receptors in Saccharomyces cerevisiae</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2004</year>
          <volume>324</volume>
          <issue>1</issue>
          <fpage>171</fpage>
          <lpage>177</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbrc.2004.09.034</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Pausch MH, Lai M, Tseng E, Paulsen J, Bates B, Kwak S (2004) Functional expression of human and mouse P2Y12 receptors in Saccharomyces cerevisiae. Biochem Biophys Res Commun 324(1):171&#x2013;177 <pub-id pub-id-type="pmid">15464998</pub-id></citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ault</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Broach</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Creation of GPCR-based chemical sensors by directed evolution in yeast</article-title>
          <source>Protein Eng Des Sel</source>
          <year>2006</year>
          <volume>19</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1093/protein/gzi069</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Ault AD, Broach JR (2006) Creation of GPCR-based chemical sensors by directed evolution in yeast. Protein Eng Des Sel 19(1):1&#x2013;8 <pub-id pub-id-type="pmid">16263727</pub-id></citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ding</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kunapuli</surname>
              <given-names>SP</given-names>
            </name>
          </person-group>
          <article-title>Identification of a potent inverse agonist at a constitutively active mutant of human P2Y12 receptor</article-title>
          <source>Mol Pharmacol</source>
          <year>2006</year>
          <volume>69</volume>
          <issue>1</issue>
          <fpage>338</fpage>
          <lpage>345</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ding Z, Kim S, Kunapuli SP (2006) Identification of a potent inverse agonist at a constitutively active mutant of human P2Y12 receptor. Mol Pharmacol 69(1):338&#x2013;345 <pub-id pub-id-type="pmid">16234484</pub-id></citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andre</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Delaney</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>LaRocca</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries</article-title>
          <source>J Clin Invest</source>
          <year>2003</year>
          <volume>112</volume>
          <issue>3</issue>
          <fpage>398</fpage>
          <lpage>406</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI200317864</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Andre P, Delaney SM, LaRocca T et al (2003) P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest 112(3):398&#x2013;406 <pub-id pub-id-type="pmid">12897207</pub-id></citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haynes</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Hollopeter</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The P2Y12 receptor regulates microglial activation by extracellular nucleotides</article-title>
          <source>Nat Neurosci</source>
          <year>2006</year>
          <volume>9</volume>
          <issue>12</issue>
          <fpage>1512</fpage>
          <lpage>1519</lpage>
          <pub-id pub-id-type="doi">10.1038/nn1805</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Haynes SE, Hollopeter G, Yang G et al (2006) The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 9(12):1512&#x2013;1519 <pub-id pub-id-type="pmid">17115040</pub-id></citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schoneberg</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Biebermann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hermsdorf</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Rompler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sangkuhl</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Mutant G-protein-coupled receptors as a cause of human diseases</article-title>
          <source>Pharmacol Ther</source>
          <year>2004</year>
          <volume>104</volume>
          <issue>3</issue>
          <fpage>173</fpage>
          <lpage>206</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pharmthera.2004.08.008</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Schoneberg T, Schulz A, Biebermann H, Hermsdorf T, Rompler H, Sangkuhl K (2004) Mutant G-protein-coupled receptors as a cause of human diseases. Pharmacol Ther 104(3):173&#x2013;206 <pub-id pub-id-type="pmid">15556674</pub-id></citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Remijn</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>IJsseldijk</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Strunk</surname>
              <given-names>AL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Novel molecular defect in the platelet ADP receptor P2Y12 of a patient with haemorrhagic diathesis</article-title>
          <source>Clin Chem Lab Med</source>
          <year>2007</year>
          <volume>45</volume>
          <issue>2</issue>
          <fpage>187</fpage>
          <lpage>189</lpage>
          <pub-id pub-id-type="doi">10.1515/CCLM.2007.036</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Remijn JA, IJsseldijk MJ, Strunk AL et al (2007) Novel molecular defect in the platelet ADP receptor P2Y12 of a patient with haemorrhagic diathesis. Clin Chem Lab Med 45(2):187&#x2013;189 <pub-id pub-id-type="pmid">17311506</pub-id></citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shiraga</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miyata</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Impaired platelet function in a patient with P2Y12 deficiency caused by a mutation in the translation initiation codon</article-title>
          <source>J Thromb Haemost</source>
          <year>2005</year>
          <volume>3</volume>
          <issue>10</issue>
          <fpage>2315</fpage>
          <lpage>2323</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1538-7836.2005.01554.x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Shiraga M, Miyata S, Kato H et al (2005) Impaired platelet function in a patient with P2Y12 deficiency caused by a mutation in the translation initiation codon. J Thromb Haemost 3(10):2315&#x2013;2323 <pub-id pub-id-type="pmid">16194207</pub-id></citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cattaneo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zighetti</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Lombardi</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2003</year>
          <volume>100</volume>
          <issue>4</issue>
          <fpage>1978</fpage>
          <lpage>1983</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0437879100</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Cattaneo M, Zighetti ML, Lombardi R et al (2003) Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding. Proc Natl Acad Sci USA 100(4):1978&#x2013;1983 <pub-id pub-id-type="pmid">12578987</pub-id></citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fontana</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dupont</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gandrille</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects</article-title>
          <source>Circulation</source>
          <year>2003</year>
          <volume>108</volume>
          <issue>8</issue>
          <fpage>989</fpage>
          <lpage>995</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.0000085073.69189.88</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Fontana P, Dupont A, Gandrille S et al (2003) Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 108(8):989&#x2013;995 <pub-id pub-id-type="pmid">12912815</pub-id></citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fontana</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gaussem</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Aiach</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fiessinger</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Emmerich</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Reny</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>P2Y12 H2 haplotype is associated with peripheral arterial disease: a case-control study</article-title>
          <source>Circulation</source>
          <year>2003</year>
          <volume>108</volume>
          <issue>24</issue>
          <fpage>2971</fpage>
          <lpage>2973</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.0000106904.80795.35</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Fontana P, Gaussem P, Aiach M, Fiessinger JN, Emmerich J, Reny JL (2003) P2Y12 H2 haplotype is associated with peripheral arterial disease: a case-control study. Circulation 108(24):2971&#x2013;2973 <pub-id pub-id-type="pmid">14662702</pub-id></citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schettert</surname>
              <given-names>IT</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Hueb</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Krieger</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Association between platelet P2Y12 haplotype and risk of cardiovascular events in chronic coronary disease</article-title>
          <source>Thromb Res</source>
          <year>2006</year>
          <volume>118</volume>
          <issue>6</issue>
          <fpage>679</fpage>
          <lpage>683</lpage>
          <pub-id pub-id-type="doi">10.1016/j.thromres.2005.11.009</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Schettert IT, Pereira AC, Lopes NH, Hueb WA, Krieger JE (2006) Association between platelet P2Y12 haplotype and risk of cardiovascular events in chronic coronary disease. Thromb Res 118(6):679&#x2013;683 <pub-id pub-id-type="pmid">16405973</pub-id></citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ziegler</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schillinger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Funk</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease</article-title>
          <source>Stroke</source>
          <year>2005</year>
          <volume>36</volume>
          <issue>7</issue>
          <fpage>1394</fpage>
          <lpage>1399</lpage>
          <pub-id pub-id-type="doi">10.1161/01.STR.0000169922.79281.a5</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Ziegler S, Schillinger M, Funk M et al (2005) Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease. Stroke 36(7):1394&#x2013;1399 <pub-id pub-id-type="pmid">15933261</pub-id></citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <collab>International HapMap Consortium</collab>
          </person-group>
          <article-title>A haplotype map of the human genome</article-title>
          <source>Nature</source>
          <year>2005</year>
          <volume>437</volume>
          <issue>7063</issue>
          <fpage>1299</fpage>
          <lpage>1320</lpage>
          <pub-id pub-id-type="doi">10.1038/nature04226</pub-id>
        </citation>
        <citation citation-type="display-unstructured">International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437(7063):1299&#x2013;1320 <pub-id pub-id-type="pmid">16255080</pub-id></citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bamshad</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wooding</surname>
              <given-names>SP</given-names>
            </name>
          </person-group>
          <article-title>Signatures of natural selection in the human genome</article-title>
          <source>Nat Rev Genet</source>
          <year>2003</year>
          <volume>4</volume>
          <issue>2</issue>
          <fpage>99</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="doi">10.1038/nrg999</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Bamshad M, Wooding SP (2003) Signatures of natural selection in the human genome. Nat Rev Genet 4(2):99&#x2013;111 <pub-id pub-id-type="pmid">12560807</pub-id></citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nielsen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bustamante</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>AG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A scan for positively selected genes in the genomes of humans and chimpanzees</article-title>
          <source>PLoS Biol</source>
          <year>2005</year>
          <volume>3</volume>
          <issue>6</issue>
          <fpage>e170</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pbio.0030170</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Nielsen R, Bustamante C, Clark AG et al (2005) A scan for positively selected genes in the genomes of humans and chimpanzees. PLoS Biol 3(6):e170 <pub-id pub-id-type="pmid">15869325</pub-id></citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nielsen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Williamson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hubisz</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Bustamante</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Genomic scans for selective sweeps using SNP data</article-title>
          <source>Genome Res</source>
          <year>2005</year>
          <volume>15</volume>
          <issue>11</issue>
          <fpage>1566</fpage>
          <lpage>1575</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.4252305</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Nielsen R, Williamson S, Kim Y, Hubisz MJ, Clark AG, Bustamante C (2005) Genomic scans for selective sweeps using SNP data. Genome Res 15(11):1566&#x2013;1575 <pub-id pub-id-type="pmid">16251466</pub-id></citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tang</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Thornton</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Stoneking</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A new approach for using genome scans to detect recent positive selection in the human genome</article-title>
          <source>PLoS Biol</source>
          <year>2007</year>
          <volume>5</volume>
          <issue>7</issue>
          <fpage>e171</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pbio.0050171</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Tang K, Thornton KR, Stoneking M (2007) A new approach for using genome scans to detect recent positive selection in the human genome. PLoS Biol 5(7):e171 <pub-id pub-id-type="pmid">17579516</pub-id></citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kimura</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fujimoto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tokunaga</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohashi</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A practical genome scan for population-specific strong selective sweeps that have reached fixation</article-title>
          <source>PLoS ONE</source>
          <year>2007</year>
          <volume>2</volume>
          <fpage>e286</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0000286</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Kimura R, Fujimoto A, Tokunaga K, Ohashi J (2007) A practical genome scan for population-specific strong selective sweeps that have reached fixation. PLoS ONE 2:e286 <pub-id pub-id-type="pmid">17356696</pub-id></citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Joensuu</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hamalainen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lehesjoki</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Chapelle</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sankila</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>A sequence-ready map of the Usher syndrome type III critical region on chromosome 3q</article-title>
          <source>Genomics</source>
          <year>2000</year>
          <volume>63</volume>
          <issue>3</issue>
          <fpage>409</fpage>
          <lpage>416</lpage>
          <pub-id pub-id-type="doi">10.1006/geno.1999.6096</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Joensuu T, Hamalainen R, Lehesjoki AE, de la Chapelle A, Sankila EM (2000) A sequence-ready map of the Usher syndrome type III critical region on chromosome 3q. Genomics 63(3):409&#x2013;416 <pub-id pub-id-type="pmid">10704288</pub-id></citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bedard</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tremblay</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Chernomoretz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vallieres</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Identification of genes preferentially expressed by microglia and upregulated during cuprizone-induced inflammation</article-title>
          <source>Glia</source>
          <year>2007</year>
          <volume>55</volume>
          <issue>8</issue>
          <fpage>777</fpage>
          <lpage>789</lpage>
          <pub-id pub-id-type="doi">10.1002/glia.20477</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Bedard A, Tremblay P, Chernomoretz A, Vallieres L (2007) Identification of genes preferentially expressed by microglia and upregulated during cuprizone-induced inflammation. Glia 55(8):777&#x2013;789 <pub-id pub-id-type="pmid">17285589</pub-id></citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ballesteros</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Weinstein</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</article-title>
          <source>Methods Neurosci</source>
          <year>1995</year>
          <volume>25</volume>
          <fpage>366</fpage>
          <lpage>428</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ballesteros JA, Weinstein H (1995) Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci 25:366&#x2013;428 </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>